ImaginAb, pharmas in precompetitive push for T cell imaging biomarker

ImaginAb rallies pharmas to develop shared understanding of its T cell imaging biomarker

ImaginAb’s pharma collaboration to develop its CD8+ T cell PET imaging agent is the latest indicator that the best way to develop biomarkers for immuno-oncology is by committee.

On Monday, ImaginAb Inc. announced an up to three-year collaboration

Read the full 377 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE